-CD20 BTK COMBINATION THERAPY OF AN ANTI CD20 ANTIBODY WITH A BTK INHIBITOR

摘要

The present invention relates to the combination therapy of an anti-CD20 antibody and a BTK inhibitor for the treatment of cancer, in particular a combination therapy of CD20 expressing cancer with a type I anti-CD20 antibody or afocused humanized B-Lyl antibody and a BTK inhibitor will be.